• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Immunobiological activities of nontoxic lipid A: enhancement of nonspecific resistance in combination with trehalose dimycolate against viral infection and adjuvant effects.

作者信息

Masihi K N, Lange W, Brehmer W, Ribi E

出版信息

Int J Immunopharmacol. 1986;8(3):339-45. doi: 10.1016/0192-0561(86)90116-5.

DOI:10.1016/0192-0561(86)90116-5
PMID:3733302
Abstract

The ability of nontoxic monophosphoryl lipid A (MPL) to stimulate nonspecific resistance against viral infection was investigated. Mice pretreated intravenously with squalane-in-water emulsions of MPL, alone or in combination with other immunostimulants, were given an aerosol of influenza virus three weeks after the pretreatment. Complete protection against lethal influenza virus infection was conferred when MPL was combined with trehalose dimycolate (TDM). The protective activity of MPL plus TDM combination was corroborated by a significant reduction of the lung virus titers. Combination of lower doses of MPL with TDM extracted from Mycobacterium bovis, but not with that of M. phlei, induced significant resistance to influenza virus. Preparations containing MPL alone, or combined with mycobacterial cell wall skeleton or muramyl dipeptide, were not effective. The adjuvant activity of MPL on bivalent influenza subunit vaccine was also studied. The primary antibody responses to influenza A and influenza B antigens were enhanced by the addition of MPL and were higher than the vaccine associated with aluminum hydroxide. The adjuvant activity of MPL was confirmed by the elevated secondary response. High levels of circulating antibodies were still present in the MPL group when antibody titers in the controls were waning.

摘要

相似文献

1
Immunobiological activities of nontoxic lipid A: enhancement of nonspecific resistance in combination with trehalose dimycolate against viral infection and adjuvant effects.
Int J Immunopharmacol. 1986;8(3):339-45. doi: 10.1016/0192-0561(86)90116-5.
2
Correlation between augmented resistance to influenza virus infection and histological changes in lung of mice treated with trehalose-6,6'-dimycolate.海藻糖-6,6'-二霉菌酸酯处理的小鼠对流感病毒感染增强的抵抗力与肺组织学变化之间的相关性
J Biol Response Mod. 1988 Oct;7(5):473-82.
3
Stimulation of chemiluminescence and resistance against aerogenic influenza virus infection by synthetic muramyl dipeptide combined with trehalose dimycolate.合成的胞壁酰二肽与海藻糖二霉菌酸酯联合使用对化学发光的刺激作用及对空气传播型流感病毒感染的抵抗力。
Infect Immun. 1984 Jan;43(1):233-7. doi: 10.1128/iai.43.1.233-237.1984.
4
Protective effect of muramyl dipeptide analogs in combination with trehalose dimycolate against aerogenic influenza virus and Mycobacterium tuberculosis infections in mice.胞壁酰二肽类似物与海藻糖二霉菌酸酯联合使用对小鼠气源性流感病毒和结核分枝杆菌感染的保护作用。
J Biol Response Mod. 1984 Dec;3(6):663-71.
5
Trehalose dimycolate enhances resistance to infection in neutropenic animals.海藻糖二霉菌酸酯增强中性粒细胞减少动物对感染的抵抗力。
Infect Immun. 1989 Aug;57(8):2495-501. doi: 10.1128/iai.57.8.2495-2501.1989.
6
Mechanisms of augmented resistance of cyclosporin A-treated mice to influenza virus infection by trehalose-6,6'-dimycolate.海藻糖-6,6'-二霉菌酸酯增强环孢素A处理小鼠对流感病毒感染抵抗力的机制
Microbiol Immunol. 1992;36(10):1061-75. doi: 10.1111/j.1348-0421.1992.tb02110.x.
7
Effects of mycobacterial fractions and muramyl dipeptide on the resistance of mice to aerogenic influenza virus infection.分枝杆菌组分与胞壁酰二肽对小鼠抗空气传播性流感病毒感染抵抗力的影响。
Int J Immunopharmacol. 1983;5(5):403-10. doi: 10.1016/0192-0561(83)90015-2.
8
Monophosphoryl lipid A-induced immune enhancement of Brucella abortus salt-extractable protein and lipopolysaccharide vaccines in BALB/c mice.单磷酰脂质A诱导BALB/c小鼠对流产布鲁氏菌盐提取物蛋白和脂多糖疫苗的免疫增强作用。
Am J Vet Res. 1992 Oct;53(10):1900-7.
9
Vaccination with liposomal leishmanial antigens adjuvanted with monophosphoryl lipid-trehalose dicorynomycolate (MPL-TDM) confers long-term protection against visceral leishmaniasis through a human administrable route.用脂质体利什曼原虫抗原与单磷酰脂质-海藻糖二脂(MPL-TDM)佐剂免疫接种,通过可人类给药途径对内脏利什曼病提供长期保护。
Mol Pharm. 2012 Jan 1;9(1):59-70. doi: 10.1021/mp2002494. Epub 2011 Dec 14.
10
Effects of muramyl dipeptide and trehalose dimycolate on resistance of mice to Toxoplasma gondii and Acanthamoeba culbertsoni infections.胞壁酰二肽和海藻糖二霉菌酸酯对小鼠抵抗刚地弓形虫和卡氏棘阿米巴感染的影响。
Int Arch Allergy Appl Immunol. 1986;81(2):112-7. doi: 10.1159/000234118.

引用本文的文献

1
Nano/Micro-Enabled Modification and Innovation of Conventional Adjuvants for Next-Generation Vaccines.用于下一代疫苗的传统佐剂的纳米/微技术修饰与创新
J Funct Biomater. 2025 May 19;16(5):185. doi: 10.3390/jfb16050185.
2
Synthetic Biology-derived triterpenes as efficacious immunomodulating adjuvants.基于合成生物学的三萜类化合物作为有效的免疫调节佐剂。
Sci Rep. 2020 Oct 13;10(1):17090. doi: 10.1038/s41598-020-73868-6.
3
Phosphorylated Hexa-Acyl Disaccharides Augment Host Resistance Against Common Nosocomial Pathogens.磷酸化六酰基二糖增强宿主对常见医院病原体的抵抗力。
Crit Care Med. 2019 Nov;47(11):e930-e938. doi: 10.1097/CCM.0000000000003967.
4
The role of MyD88- and TRIF-dependent signaling in monophosphoryl lipid A-induced expansion and recruitment of innate immunocytes.髓样分化因子88(MyD88)和TIR结构域衔接蛋白诱导干扰素β(TRIF)依赖性信号传导在单磷酰脂质A诱导的固有免疫细胞扩增和募集过程中的作用
J Leukoc Biol. 2016 Dec;100(6):1311-1322. doi: 10.1189/jlb.1A0216-072R. Epub 2016 Jun 27.
5
Intratumoral delivery of low doses of anti-CD40 mAb combined with monophosphoryl lipid a induces local and systemic antitumor effects in immunocompetent and T cell-deficient mice.瘤内给予低剂量抗 CD40 mAb 联合单磷酰脂质 A 可在免疫功能正常和 T 细胞缺陷小鼠中诱导局部和全身抗肿瘤作用。
J Immunother. 2013 Jan;36(1):29-40. doi: 10.1097/CJI.0b013e3182780f61.
6
Adjuvants for Leishmania vaccines: from models to clinical application.利什曼病疫苗的佐剂:从模型到临床应用。
Front Immunol. 2012 Jun 11;3:144. doi: 10.3389/fimmu.2012.00144. eCollection 2012.
7
Carbohydrate-based immune adjuvants.基于碳水化合物的免疫佐剂。
Expert Rev Vaccines. 2011 Apr;10(4):523-37. doi: 10.1586/erv.11.30.
8
Toll or toll-free adjuvant path toward the optimal vaccine development.通往最佳疫苗开发的Toll或免费佐剂途径。
J Clin Immunol. 2007 Jul;27(4):363-71. doi: 10.1007/s10875-007-9087-x. Epub 2007 Mar 17.
9
Adjuvant-enhanced antibody responses to recombinant proteins correlates with protection of mice and monkeys to orthopoxvirus challenges.佐剂增强的针对重组蛋白的抗体反应与小鼠和猴子对正痘病毒攻击的保护作用相关。
Vaccine. 2007 Apr 12;25(15):2787-99. doi: 10.1016/j.vaccine.2006.12.037. Epub 2007 Jan 3.
10
Synthetic toll-like receptor 4 agonists stimulate innate resistance to infectious challenge.合成的Toll样受体4激动剂可刺激对感染性挑战的天然抵抗力。
Infect Immun. 2005 May;73(5):3044-52. doi: 10.1128/IAI.73.5.3044-3052.2005.